| INDUSTRY NEWS | ImmunoCellular Provides Update on Phase II Clinical Trial of ICT-107 for Treatment of Glioblastoma ImmunoCellular Therapeutics, Ltd. announced that it will expand its current Phase IIb trial of ICT-107 from 102 to up to 123 patients with glioblastoma multiforme and who are HLA-A1/A2 positive. [Business Wire] Press Release Dramatic Change in Patient with ALS and MG following Compassionate Use of BrainStorm’s Nurown™ Cell Therapy A patient suffering from Myasthenia Gravis and recently diagnosed with ALS reported that he has experienced visible improvement in his speech, walking, balance, posture, muscle strength, appetite, digestion, and weight gain following compassionate treatment with BrainStorm’s NurOwn cell therapy. [BrainStorm Cell Therapeutics Inc.] Press Release The World’s Largest Open Access Journal, PLoS ONE, Has Teamed Up with One of the Fastest Growing Multidisciplinary Medical Associations, SMBT, to Better Educate Physicians, Scientists, Engineers and Policy Makers on Key Cross-Disciplinary Scientific Advances The Society for Brain Mapping & Therapeutics (SBMT) will launch a new Collection with PLoS ONE called: The NeuroMapping & Therapeutics Collection. [PR Newswire] Press Release |
|
|
|